Display options
Cite
Seno S, Kitajima K, Inokuchi G, et al. FDG-PET findings of Ameloblastoma: a case report. Springerplus. 2015;4:250doi: 10.1186/s40064-015-0998-3.
Seno, S., Kitajima, K., Inokuchi, G., Nibu, K., Itoh, T., Ejima, Y., Sasaki, R., Sugimoto, K., & Sugimura, K. (2015). FDG-PET findings of Ameloblastoma: a case report. SpringerPlus, 4250. https://doi.org/10.1186/s40064-015-0998-3
Seno, Satoshi, et al. "FDG-PET findings of Ameloblastoma: a case report." SpringerPlus vol. 4 (2015): 250. doi: https://doi.org/10.1186/s40064-015-0998-3
Seno S, Kitajima K, Inokuchi G, Nibu K, Itoh T, Ejima Y, Sasaki R, Sugimoto K, Sugimura K. FDG-PET findings of Ameloblastoma: a case report. Springerplus. 2015 Jun 11;4:250. doi: 10.1186/s40064-015-0998-3. eCollection 2015. PMID: 26101729; PMCID: PMC4474970.
Copy Download .nbib Format: NLM
Share it on

Springerplus. 2015 Jun 11;4:250. doi: 10.1186/s40064-015-0998-3. eCollection 2015.

FDG-PET findings of Ameloblastoma: a case report.

SpringerPlus

Satoshi Seno, Kazuhiro Kitajima, Go Inokuchi, Ken-Ichi Nibu, Tomoo Itoh, Yasuo Ejima, Ryohei Sasaki, Koji Sugimoto, Kazuro Sugimura

Affiliations

  1. Department of Radiology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
  2. Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
  3. Department of Diagnostic Pathology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
  4. Department of Radiology, Division of Radiation Oncology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.

PMID: 26101729 PMCID: PMC4474970 DOI: 10.1186/s40064-015-0998-3

Abstract

INTRODUCTION: Ameloblastoma is a benign odontogenic neoplasm of the jaw, rarely presenting as a malignant tumor. Although it is very important to discriminate ameloblastoma from ameloblastic carcinoma in order to decide the appropriate operative procedure, this is difficult using conventional CT and MRI.

CASE DESCRIPTIONS: We report a case of maxillar ameloblastoma in a 78-year-old man where FDG-PET/CT was useful for making this discrimination. CT demonstrated a 31 × 43 × 46-mm mass in the left posterior maxillary sinus with destruction of its posterior and lateral wall and alveolar bone. MRI demonstrated a hypo- to isointense heterogeneous pattern on T1WI, heterogeneous hyperintensity with a prominent high-signal spot on T2WI, high signal intensity on DWI reflecting restricted diffusion, and strong heterogeneous enhancement. Because FDG-PET/CT showed mild FDG uptake (SUVmax 2.40) by the mass, ameloblastoma, rather than ameloblastic carcinoma, was considered to be the correct diagnosis.

DISCUSSION AND EVALUATION: It appears that ameloblastic carcinoma shows intense FDG uptake, whereas ameloblastoma shows mild or moderate FDG uptake, and only rarely intense FDG uptake. Our experience suggests that FDG-PET/CT may be effective for discriminating ameloblastoma from ameloblastic carcinoma. Especially, in cases showing mild FDG uptake, benign ameloblastoma would seem the most likely diagnosis.

CONCLUSIONS: FDG-PET/CT may be useful as an adjunctive modality for diagnosis, treatment planning and surveillance of ameloblastoma and ameloblastic carcinoma.

Keywords: 18F-fluorodeoxyglucose (FDG); Ameloblastoma; CT; MRI; PET

References

  1. Dentomaxillofac Radiol. 2010 Oct;39(7):449-53 - PubMed
  2. Br J Oral Maxillofac Surg. 1995 Feb;33(1):47-50 - PubMed
  3. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Jul;112(1):e40-7 - PubMed
  4. Radiographics. 2006 Nov-Dec;26(6):1751-68 - PubMed
  5. J Oral Maxillofac Surg. 2008 Aug;66(8):1761-5 - PubMed
  6. Am J Clin Pathol. 1988 Oct;90(4):474-81 - PubMed
  7. Radiology. 1992 Aug;184(2):389-93 - PubMed
  8. Clin Nucl Med. 2005 Jun;30(6):450-2 - PubMed

Publication Types